| Income Statement |
| Total Revenue | 19.98M |
|
| Revenues (USD) | 19.98M |
| Cost of Revenue | 4.69M |
| Gross Profit | 15.30M |
| Operating Expenses | 15.43M |
| Research and Development Expense | 907.97K |
| Selling, General and Administrative Expense | 9.55M |
| Operating Income | -135.18K |
| Interest Expense | 4.04M |
| Net Income | -12.50M |
| Net Income Common Stock | -12.50M |
| Net Income Common Stock (USD) | -12.50M |
| Consolidated Income | -12.50M |
| Earnings per Basic Share | -0.15 |
| Earnings per Basic Share (USD) | -0.15 |
| Earnings per Diluted Share | -0.15 |
| Earning Before Interest & Taxes (EBIT) | -8.46M |
| Earning Before Interest & Taxes (USD) | -8.46M |
| Weighted Average Shares | 86.13M |
| Weighted Average Shares Diluted | 86.13M |
| Balance Sheet |
| Cash and Equivalents | 12.50M |
| Cash and Equivalents (USD) | 12.50M |
| Trade and Non-Trade Receivables | 402.50K |
| Current Assets | 17.92M |
| Property, Plant & Equipment Net | 2.27M |
| Total Assets | 32.36M |
| Debt Current | 4.44M |
| Total Debt | 106.99M |
| Current Liabilities | 13.26M |
| Debt Non-Current | 102.55M |
| Total Liabilities | 116.18M |
| Accumulated Retained Earnings (Deficit) | -200.86M |
| Accumulated Other Comprehensive Income | -7.56M |
| Shareholders Equity | -83.82M |
| Shareholders Equity (USD) | -83.82M |
| Assets Non-Current | 14.44M |
| Total Debt (USD) | 106.99M |
| Deferred Revenue | 2.49M |
| Goodwill and Intangible Assets | 215.75K |
| Inventory | 1.93M |
| Liabilities Non-Current | 102.92M |
| Trade and Non-Trade Payables | 2.23M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 637.91K |
| Net Cash Flow from Financing | 5.03M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.74M |
| Capital Expenditure | -90.74K |
| Issuance (Purchase) of Equity Shares | 30.39K |
| Issuance (Repayment) of Debt Securities | 5.00M |
| Net Cash Flow from Investing | -377.99K |
| Net Cash Flow from Operations | 3.09M |
| Share Based Compensation | 2.40M |